Health-Related Quality of Life in Patients with HR+/HER2− Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial
These analyses of NATALEE show that adding adjuvant ribociclib to an NSAI does not negatively affect HRQOL in patients with HR+/HER2- early breast cancer.
Authors
- Bożena Budny (ORCID: https://orcid.org/0000-0002-2837-5870)
- Michael Untch (ORCID: https://orcid.org/0000-0002-1233-1267)
- Arlene Chan (ORCID: https://orcid.org/0000-0003-2135-2286)
- Sherene Loi (ORCID: https://orcid.org/0000-0001-6137-9171)
- Dennis J. Slamon (ORCID: https://orcid.org/0000-0002-6330-498X)
- Peter A. Fasching (ORCID: https://orcid.org/0000-0003-4885-8471)
- Gabriel N. Hortobágyi (ORCID: https://orcid.org/0000-0002-4873-4412)
- Karen Afenjar
- Chiun‐Sheng Huang (ORCID: https://orcid.org/0000-0002-6557-211X)
- Zheng Li (ORCID: https://orcid.org/0000-0002-7655-0290)
- Ilia Ferrusi (ORCID: https://orcid.org/0000-0002-9177-9683)
- Rodrigo Fresco (ORCID: https://orcid.org/0000-0001-5342-3486)
- Andriy Danyliv (ORCID: https://orcid.org/0000-0003-3382-5976)
- DA Yardley
- Zbigniew Ireneusz Nowecki (ORCID: https://orcid.org/0000-0001-7706-8191)
- Sara A. Hurvitz (ORCID: https://orcid.org/0000-0001-7808-7191)
- Daniil Stroyakovskiy (ORCID: https://orcid.org/0000-0003-1973-1092)
- Stephen Chia (ORCID: https://orcid.org/0000-0001-7070-4386)
- Hope S. Rugo (ORCID: https://orcid.org/0000-0001-6710-4814)
- Miguel Martín (ORCID: https://orcid.org/0000-0001-9237-3231)
Institutions
- Novartis (Switzerland) (CH)
- BC Cancer Agency (CA)
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- Maria Curie-Skłodowska University (PL)
- University of California, San Francisco (US)
- Curtin University (AU)
- UCLA Health (US)
- Peter MacCallum Cancer Centre (AU)
- Hospital General Universitario Gregorio Marañón (ES)
- Universitätsklinikum Erlangen (DE)
- Fred Hutch Cancer Center (US)
- Sarah Cannon (US)
- Translational Research in Oncology (FR)
- USC Norris Comprehensive Cancer Center (US)
- Novartis (United States) (US)
- Lublin Oncology Center (PL)
- National Taiwan University Hospital (TW)
- Tennessee Oncology (US)
- Comprehensive Cancer Center Erlangen (DE)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Helios Hospital Berlin-Buch (DE)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- Tris Pharma (United States) (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
- Moscow City Oncology Hospital №62 (RU)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1158/1078-0432.ccr-24-1724
- Citations
- 7
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 10.63